What If You Invested in International Flavors & Fragrances Inc. (IFF)?

IFF

International Flavors & Fragrances Inc. Calculate historical returns with real market data.

What if you invested $1000 in IFF on Jan 1, 2020?

Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.

📈
Your investment journey awaits!
Click "Calculate Investment" to see your potential returns
Current Value
$XX,XXX
Return
+XXX%
CAGR
X.XX%
vs SPY
+XX%

Historical Annual Returns

Over the past 20 years, International Flavors & Fragrances Inc. has delivered an average annual return of 8.9%. The stock peaked in 2006 with a massive +48.6% gain, while investors faced a downturn in 2008 (-35.4%). Overall, the stock finished in the green 12 times out of 20 years.

Avg Return

+8.9%

Win Rate

60%

12W - 8L

Best

+48.6%

2006

Worst

-35.4%

2008

Performance Consistency

12 Positive8 Negative

About International Flavors & Fragrances Inc.

Visit Website ↗

International Flavors & Fragrances Inc. (IFF) is an American corporation that specializes in creating and manufacturing products across taste, texture, scent, nutrition, enzymes, cultures, soy proteins, and probiotics categories. It provides flavors, fragrances, ingredients, and bioscience solutions to a diverse range of industries, including food, beverage, health, and personal care sectors.

HeadquartersNew York City, United States
Founded1958

Key Business Segments

Taste

Develops and manufactures flavors for food and beverage applications.

Scent

Creates and produces fragrances for perfumes, cosmetics, and household products.

Health & Biosciences

Offers enzymes, cultures, soy proteins, and probiotics for various applications, including food, beverage, and dietary supplements.

Key Innovations

  • ✓Sustainability-driven innovation across its product portfolio, focusing on eco-friendly solutions.
  • ✓Advancements in digital transformation to enhance R&D, production, and customer engagement.
  • ✓Expansion and innovation within its biosciences portfolio, developing cutting-edge ingredients and solutions.

Historical Milestones

1958

Formed through the merger of Polak & Schwarz and van Ameringen-Haebler.

2024

Reported net sales of $11.484 billion, demonstrating its strong market position.